RecruitingNot Applicable

Multimodal Analgesia vs. Femoral Block in ACL Surgery

Turkey (Türkiye)62 participantsStarted 2025-01-21

Plain-language summary

This study aims to compare the effects of a preemptive multimodal intravenous analgesia protocol and a femoral triangle block on early postoperative rehabilitation compliance in patients undergoing anterior cruciate ligament (ACL) reconstruction under general anesthesia. Adult patients aged 18 to 65 will be randomized to receive either multimodal intravenous analgesia or femoral triangle block prior to surgery. Rehabilitation compliance will be evaluated using the straight leg raise test, sit-to-stand success, and pain scores at multiple postoperative time points. Secondary outcomes include opioid consumption, incidence of opioid-related side effects.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Age: 18 years or older. Condition: Patients scheduled for anterior cruciate ligament (ACL) reconstruction surgery. ASA Classification: Patients classified as ASA I, II, or III. Orientation: Patients who are fully oriented and can cooperate with study procedures. Consent: Patients capable of providing informed consent to participate in the study. Exclusion Criteria: Informed Consent: Patients unable to provide informed consent. BMI: Patients with a BMI of ≥30 kg/m². Allergy: Known allergy to local anesthetics. Orientation and Cooperation: Patients who are not fully oriented or cannot cooperate with study procedures. Additional Trauma: Patients with other traumatic injuries requiring opioid analgesia. Neuropathic Pain History: Patients with a history of neuropathic pain. Chronic Pain Syndrome: Patients with a history of chronic pain syndrome.

What they're measuring

Compliance with Straight Leg Raise Test (SLR)

Timeframe: Postoperative 2, 6, 12 and 24 hours

Standing Ability

Timeframe: Postoperative 2,6,12 and 24 hours

Trial details

NCT IDNCT06936995

SponsorAnkara University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-25

Contact for this trial

SEVDE NUR AYDIN KUŞSAN, Research Assistant

+905398561592 sevdenuraydiiin@gmail.com